Announcements Trials
Browse Landscape

Status

No longer available 3Available 1

Sponsor Class

OTHER 4INDUSTRY 3

Study Type

Interventional 307Observational 116Expanded_access 4

Sponsor

Cancer Type

Genitourinary 20CNS 18Gastrointestinal 15Other hematologic neoplasm 14Sarcoma 12Endocrine 11Lymphoid 9Plasma cell 7Tumor-Agnostic 6Myeloid 6Breast 5NET 4Head & Neck 4Thoracic 3Other neoplasm 3Other solid neoplasm 2Gynecologic 2Dermatologic 2Classical hematology 2

Conditions

Neuroendocrine Tumors 4Neuroectodermal Tumors, Primitive 1Neoplasms 1Liposarcoma 1Insulinoma 1Hypoglycemia 1Hyperinsulinism 1Fibrosarcoma 1Carcinoma, Medullary 1Carcinoid Tumor 1Adenoma, Islet Cell 1

Interventions

Ga(III)-DOTATOC 2Gallium-68 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Expanded_access × NET × Clear all
NCT07262970 2025-12-04

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

Rezolute

Available
EndocrineNETSarcoma

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

NCT02174679 2020-07-27

68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)

Jonsson Comprehensive Cancer Center

No longer available
EndocrineNET

Carcinoma, Medullary, Neuroendocrine Tumors

NCT02375464 2016-11-08

Gallium-68 DOTATOC for Management of Neuroendocrine Tumors

Northwell Health

No longer available
EndocrineNET

Carcinoid Tumor, Neuroendocrine Tumors

NCT02358018 2016-11-02

68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access Trial

Memorial Sloan Kettering Cancer Center

No longer available
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡